These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17954951

  • 21. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
    Robben JH, Sze M, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F253-60. PubMed ID: 16926443
    [Abstract] [Full Text] [Related]

  • 22. Gain-of-function mutations of the V2 vasopressin receptor in nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a cell-based assay to assess constitutive water reabsorption.
    Ranieri M, Tamma G, Pellegrino T, Vezzi V, Ambrosio C, Grò C, Di Mise A, Costa T, Valenti G, Cotecchia S.
    Pflugers Arch; 2019 Oct; 471(10):1291-1304. PubMed ID: 31486901
    [Abstract] [Full Text] [Related]

  • 23. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
    Ahrabi AK, Terryn S, Valenti G, Caron N, Serradeil-Le Gal C, Raufaste D, Nielsen S, Horie S, Verbavatz JM, Devuyst O.
    J Am Soc Nephrol; 2007 Jun; 18(6):1740-53. PubMed ID: 17475819
    [Abstract] [Full Text] [Related]

  • 24. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
    Loonen AJ, Knoers NV, van Os CH, Deen PM.
    Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
    [Abstract] [Full Text] [Related]

  • 25. Updates and Perspectives on Aquaporin-2 and Water Balance Disorders.
    Noda Y, Sasaki S.
    Int J Mol Sci; 2021 Nov 30; 22(23):. PubMed ID: 34884753
    [Abstract] [Full Text] [Related]

  • 26. [Water metabolism and its disturbances].
    Shoji M, Yasujima M.
    Rinsho Byori; 1999 Dec 30; 47(12):1121-7. PubMed ID: 10639821
    [Abstract] [Full Text] [Related]

  • 27. Regulation of aquaporin-2 trafficking.
    Nedvetsky PI, Tamma G, Beulshausen S, Valenti G, Rosenthal W, Klussmann E.
    Handb Exp Pharmacol; 2009 Dec 30; (190):133-57. PubMed ID: 19096775
    [Abstract] [Full Text] [Related]

  • 28. Nephrogenic diabetes insipidus.
    Bichet DG.
    Adv Chronic Kidney Dis; 2006 Apr 30; 13(2):96-104. PubMed ID: 16580609
    [Abstract] [Full Text] [Related]

  • 29. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
    Bernier V, Morello JP, Zarruk A, Debrand N, Salahpour A, Lonergan M, Arthus MF, Laperrière A, Brouard R, Bouvier M, Bichet DG.
    J Am Soc Nephrol; 2006 Jan 30; 17(1):232-43. PubMed ID: 16319185
    [Abstract] [Full Text] [Related]

  • 30. Role of aquaporins in water balance disorders.
    Knepper MA, Verbalis JG, Nielsen S.
    Curr Opin Nephrol Hypertens; 1997 Jul 30; 6(4):367-71. PubMed ID: 9263686
    [Abstract] [Full Text] [Related]

  • 31. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS.
    J Intensive Care Med; 2007 Jul 30; 22(4):216-23. PubMed ID: 17712057
    [Abstract] [Full Text] [Related]

  • 32. Novel signalling pathways in nephrogenic syndrome of inappropriate antidiuresis: functional implication of site-specific AQP2 phosphorylation.
    Venneri M, Vezzi V, Di Mise A, Ranieri M, Centrone M, Tamma G, Nejsum LN, Valenti G.
    J Physiol; 2024 Jul 30; 602(13):3169-3189. PubMed ID: 36823952
    [Abstract] [Full Text] [Related]

  • 33. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
    Morin D.
    Nephrol Ther; 2014 Dec 30; 10(7):538-46. PubMed ID: 25449762
    [Abstract] [Full Text] [Related]

  • 34. Hyponatremia and hypernatremia: disorders of water balance.
    Agrawal V, Agarwal M, Joshi SR, Ghosh AK.
    J Assoc Physicians India; 2008 Dec 30; 56():956-64. PubMed ID: 19322975
    [Abstract] [Full Text] [Related]

  • 35. Hyponatremia and antidiuresis syndrome.
    Vantyghem MC, Balavoine AS, Wémeau JL, Douillard C.
    Ann Endocrinol (Paris); 2011 Dec 30; 72(6):500-12. PubMed ID: 22119069
    [Abstract] [Full Text] [Related]

  • 36. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI, Cho HY, Park HW, Ha IS, Choi Y.
    Nephrology (Carlton); 2007 Apr 30; 12(2):113-7. PubMed ID: 17371330
    [Abstract] [Full Text] [Related]

  • 37. Vasopressin V2 receptor antagonists.
    Wong LL, Verbalis JG.
    Cardiovasc Res; 2001 Aug 15; 51(3):391-402. PubMed ID: 11476729
    [Abstract] [Full Text] [Related]

  • 38. Neurological impact of vasopressin dysregulation and hyponatremia.
    Bhardwaj A.
    Ann Neurol; 2006 Feb 15; 59(2):229-36. PubMed ID: 16437573
    [Abstract] [Full Text] [Related]

  • 39. Hyponatremia in psychiatric patients: update on evaluation and management.
    Siegel AJ.
    Harv Rev Psychiatry; 2008 Feb 15; 16(1):13-24. PubMed ID: 18306096
    [Abstract] [Full Text] [Related]

  • 40. [Hormonal dysnatremia].
    Karaca P, Desailloud R.
    Ann Endocrinol (Paris); 2013 Oct 15; 74 Suppl 1():S42-51. PubMed ID: 24356291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.